Sex differences in Parkinson’s disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378 · see citing works

Parkinson's disease: clinical features and diagnosis

Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720 · see citing works

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

Hely, M. A., Reid, W. G. J., ADENA, M. A., Halliday, G. M., & Morris, J. G. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,245 · see citing works

Parkinson's Disease

Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,041 · see citing works

Mitochondrial metabolism of reactive oxygen species

Andreyev, A. Y., Kushnareva, Y. E., & Starkov, A. A. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0102-7 · Cited by 1,336 · see citing works

MONOAMINE OXIDASE: From Genes to Behavior

Shih, J. C., Chen, K., & Ridd, M. J. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.197 · Cited by 1,211 · see citing works

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200 · see citing works

Parkinson's disease. Second of two parts.

Lang, A., & Lozano, A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391607 · Cited by 1,193 · see citing works

The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease

Martínez‐Martín, P., Rodríguez‐Blázquez, C., Kurtis, M. M., Chaudhuri, К. R., & on Behalf of the NMSS Validation Group (2011) · Movement Disorders · doi:10.1002/mds.23462 · Cited by 1,003 · see citing works

Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder

Postuma, R. B., Gagnon, J., Vendette, M., Fantini, M. L., Massicotte-Marquez, J., & Montplaisir, J. Y. (2008) · Neurology · doi:10.1212/01.wnl.0000340980.19702.6e · Cited by 779 · see citing works

Gender differences in Parkinson's disease

Haaxma, C. A., Bloem, B. R., Borm, G. F., Oyen, W. J. G., Leenders, K. L., Eshuis, S. A., Booij, J., Dluzen, D. E., & Horstink, M. W. I. M. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.103788 · Cited by 744 · see citing works

Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines

Gillies, G. E., & McArthur, S. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002071 · Cited by 733 · see citing works

The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis

Hirsch, L., Jetté, N., Frolkis, A. D., Steeves, T. D. L., & Pringsheim, T. M. (2016) · Neuroepidemiology · doi:10.1159/000445751 · Cited by 683 · see citing works

DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

Hong, Z., Shi, M., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D., Jankovic, J., Zabetian, C. P., Leverenz, J. B., Baird, G., et al. (2010) · Brain · doi:10.1093/brain/awq008 · Cited by 615 · see citing works

Sex differences in rates of depression: cross-national perspectives

Weissman, M. M. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90025-f · Cited by 553 · see citing works

Parkinson’s disease and parkinsonism in a longitudinal study: Two-fold higher incidence in men

Baldereschi, M., Di Carlo, A., Rocca, W. A., Vanni, P., Maggi, S., Perissinotto, E., Grigoletto, F., Amaducci, L., & Inzitari, D. (2000) · Neurology · doi:10.1212/wnl.55.9.1358 · Cited by 526 · see citing works

Classic and New Animal Models of Parkinson's Disease

Blesa, J., Phani, S., Jackson-Lewis, V. R., & Przedborski, S. (2012) · BioMed Research International · doi:10.1155/2012/845618 · Cited by 502 · see citing works

Sex differences in Parkinson’s disease

Gillies, G. E., Pienaar, I. S., Vohra, S., & Qamhawi, Z. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.02.002 · Cited by 495 · see citing works

Estrogen Prevents the Lipopolysaccharide-Induced Inflammatory Response in Microglia

Vegeto, E., Bonincontro, C., Pollio, G., Sala, A., Viappiani, S., Nardi, F., Brusadelli, A., Viviani, B., Ciana, P., & Maggi, A. C. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01809.2001 · Cited by 474 · see citing works

MPTP Mouse Models of Parkinson’s Disease: An Update

Meredith, G. E., & Rademacher, D. J. (2011) · Journal of Parkinson's Disease · doi:10.3233/jpd-2011-11023 · Cited by 471 · see citing works

Astrocytic modulation of blood brain barrier: perspectives on Parkinson’s disease

Cabezas, R., Ávila, M. F., González, J., El-Bachá, R. D. S., Báez-Jurado, E., García‐Segura, L. M., Jurado-Coronel, J. C., Capani, F., Cardona‐Gómez, G. P., & Barreto, G. E. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00211 · Cited by 453 · see citing works

Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease

Tokuda, T., Salem, S. A., Allsop, D., Mizuno, T., Nakagawa, M., Qureshi, M. M., Locascio, J. J., Schlossmacher, M. G., & El-Agnaf, O. M. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.024 · Cited by 425 · see citing works

Gender differences in Parkinson's disease: Clinical characteristics and cognition

Miller, I. N., & Cronin‐Golomb, A. (2010) · Movement Disorders · doi:10.1002/mds.23388 · Cited by 405 · see citing works

Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease

Mosley, R. L., Benner, E. J., Kadiu, I., Thomas, M., Boska, M. D., Hasan, K. M., Laurie, C. D., & Gendelman, H. E. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.006 · Cited by 388 · see citing works

Effect of age and gender on dopamine transporter imaging with [ 123 I]FP-CIT SPET in healthy volunteers

Lavalaye, J., Booij, J., Reneman, L., Habraken, J. B. A., & van Royen, E. A. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590000279 · Cited by 305 · see citing works

The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort

Szewczyk‐Królikowski, K., Tomlinson, P. R., Nithi, K. A., Wade‐Martins, R., Talbot, K., Ben‐Shlomo, Y., & Hu, M. T. M. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.09.025 · Cited by 293 · see citing works

Effects of natural antioxidants in neurodegenerative disease

Albarracín, S. L., Stab, B., Casas, Z., Sutachan, J. J., Samudio, I. J., González, J., Gonzalo, L., Capani, F., Morales, L., & Barreto, G. E. (2012) · Nutritional Neuroscience · doi:10.1179/1476830511y.0000000028 · Cited by 273 · see citing works

The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity

Miller, D. B., Ali, S. F., O'Callaghan, J. P., & Laws, S. C. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08230.x · Cited by 263 · see citing works

Effects of Methylphenidate on Attention Deficits After Traumatic Brain Injury

Whyte, J., Hart, T., Vaccaro, M. J., Grieb-Neff, P., Risser, A. H., Polansky, M., & Coslett, H. B. (2004) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/01.phm.0000128789.75375.d3 · Cited by 261 · see citing works

Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions

Suzuki, S., Brown, C. M., Cruz, C. D. D., Yang, E., Bridwell, D. A., & Wise, P. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610394104 · Cited by 257 · see citing works

Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London

Schrag, A. E., Ben‐Shlomo, Y., & Quinn, N. P. (2000) · BMJ · doi:10.1136/bmj.321.7252.21 · Cited by 255 · see citing works

Repression of interleukin‐6 gene expression by 17β‐estradiol:

Ray, P., Ghosh, S., Zhang, D.-H., & Ray, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00487-0 · Cited by 254 · see citing works

Mitochondrial dysfunction in Parkinson's disease

Greenamyre, J. T., MacKenzie, G. M., Peng, T., & Stephans, S. E. (1999) · Biochemical Society Symposia · doi:10.1042/bss0660085 · Cited by 248 · see citing works

Mechanism of 6‐hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6‐hydroxydopamine‐induced degeneration of dopaminergic neurons

Rodríguez‐Pallares, J., Parga, J. A., Muñoz, A., Rey, P., Guerra, M. J., & Labandeira-García, J. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04699.x · Cited by 232 · see citing works

Effects of gender on nigral gene expression and parkinson disease

Cantuti‐Castelvetri, I., Keller-McGandy, C. E., Bouzou, B., Asteris, G., Clark, T. W., Frosch, M. P., & Standaert, D. G. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.02.009 · Cited by 229 · see citing works

Expression and function of inducible nitric oxide synthase in neurons

Heneka, M. T., & Feinstein, D. L. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00246-6 · Cited by 226 · see citing works

Inflammatory mechanisms and oxidative stress as key factors responsible for progression of neurodegeneration: role of brain innate immune system

Leszek, J., E. Barreto, G., G|siorowski, K., Koutsouraki, E., Ávila-Rodrigues, M., & Aliev, G. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160202125914 · Cited by 206 · cited 1× · see citing works

A Review of the Health-Related Quality of Life and Economic Impact of Parkinson??s Disease

Dowding, C. H., Shenton, C. L., & Salek, S. (2006) · Drugs & Aging · doi:10.2165/00002512-200623090-00001 · Cited by 203 · see citing works

Sex differences in Parkinson's disease and other movement disorders

Smith, K. M., & Dahodwala, N. A. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.03.010 · Cited by 186 · see citing works

Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease

Solla, P., Cannas, A., Ibba, F. C., Loi, F., Corona, M., Orofino, G., Marrosu, M. G., & Marrosu, F. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.026 · Cited by 177 · see citing works

Estrogen as a neuroprotectant against MPTP-Induced neurotoxicity in C57/B1 mice

Dluzen, D. E., McDermott, J. L., & Liu, B. (1996) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(96)00086-4 · Cited by 163 · see citing works

Prevalence of Movement Disorders in Elderly Community Residents

Moghal, S., Rajput, A. H., D'Arcy, C., & Rajput, R. (1994) · Neuroepidemiology · doi:10.1159/000110376 · Cited by 153 · see citing works

The role of androgens in cognition and brain aging in men

Janowsky, J. S. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.007 · Cited by 145 · see citing works

Estrogen Prevents Neuroprotection by Caffeine in the Mouse 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease

Xu, K., Xu, Y., Brown-Jermyn, D., Chen, J., Ascherio, A., Dluzen, D. E., & Schwarzschild, M. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3008-05.2006 · Cited by 142 · see citing works

Biological factors underlying sex differences in neurological disorders

Loke, H., Harley, V. R., & Lee, J. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.05.024 · Cited by 141 · see citing works

Evidence for Gender-Specific Transcriptional Profiles of Nigral Dopamine Neurons in Parkinson Disease

Šimunović, F., Yi, M., Wang, Y., Stephens, R. M., & Sonntag, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008856 · Cited by 141 · see citing works

Cellular and molecular mechanisms of antioxidants in Parkinson's disease

Sutachan, J. J., Casas, Z., Albarracín, S. L., Stab, B. R., Samudio, I. J., González, J., Morales, L., & Barreto, G. E. (2012) · Nutritional Neuroscience · doi:10.1179/1476830511y.0000000033 · Cited by 123 · see citing works

Brain dopamine transporter: gender differences and effect of chronic haloperidol

Rivest, R., Falardeau, P., & Paolo, T. D. (1995) · Brain Research · doi:10.1016/0006-8993(95)00611-s · Cited by 122 · see citing works

Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in North East Scotland: The PINE study

Caslake, R., Taylor, K. S. M., SCOTT, N. W., Gordon, J. C., Harris, C., Wilde, K., Murray, A. D., & Counsell, C. E. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.01.014 · Cited by 102 · see citing works

Sex differences in Parkinson’s disease

Lubomski, M., Rushworth, R. L., Lee, W., Bertram, K., & Williams, D. R. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.12.016 · Cited by 102 · see citing works

The human testis‐determining factor SRY localizes in midbrain dopamine neurons and regulates multiple components of catecholamine synthesis and metabolism

Czech, D., Lee, J., Sim, H., Parish, C. L., Vilain, E. J. N., & Harley, V. R. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07782.x · Cited by 101 · see citing works

Mitochondrial dysfunction in Parkinson’s disease

Fukae, J., Mizuno, Y., & Hattori, N. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.12.002 · Cited by 100 · see citing works

OESTROGEN AND NIGROSTRIATAL DOPAMINERGIC NEURODEGENERATION: ANIMAL MODELS AND CLINICAL REPORTS OF PARKINSON'S DISEASE

Liu, B., & Dluzen, D. E. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04616.x · Cited by 95 · see citing works

REM sleep behavior disorder in Parkinson's disease – Is there a gender difference?

Bjørnarå, K. A., Dietrichs, E., & Toft, M. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.05.027 · Cited by 94 · see citing works

Gender and onset age-related features of non-motor symptoms of patients with Parkinson's disease – A study from Southwest China

Guo, X., Song, W., Chen, K., et al. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.06.009 · Cited by 94 · see citing works

Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: Sex-specific features

Melcangi, R. C., Giatti, S., & García‐Segura, L. M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.09.023 · Cited by 94 · see citing works

Effects of aging and gender on striatal and extrastriatal [ 123 I]FP-CIT binding in Parkinson's disease

Kaasinen, V., Joutsa, J., Noponen, T., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.01.016 · Cited by 92 · see citing works

Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system

Gao, X., & Dluzen, D. E. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00014-8 · Cited by 89 · see citing works

Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease

Antzoulatos, E., Jakowec, M. W., Petzinger, G. M., & Wood, R. I. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.03.009 · Cited by 89 · see citing works

Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation

Accolla, E. A., Caputo, E., Cogiamanian, F. M., Tamma, F., Mrakic‐Sposta, S., Marceglia, S. R. F., Egidi, M., Rampini, P. M., Locatelli, M., & Priori, A. (2007) · Movement Disorders · doi:10.1002/mds.21520 · Cited by 88 · see citing works

Prevalence of depression in Parkinson's disease: Effects of disease stage, motor subtype and gender

van der Hoek, T. C., Bus, B. A. A., Matui, P., van der Marck, M. A., Esselink, R. A. J., & Tendolkar, I. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.07.007 · Cited by 88 · see citing works

Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication

Tripanichkul, W., Sripanichkulchai, K., & Finkelstein, D. I. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.029 · Cited by 85 · see citing works

The “Gender Factor” in Wearing‐Off among Patients with Parkinson’s Disease: A Post Hoc Analysis of DEEP Study

Colombo, D., Abbruzzese, G., Antonini, A., Barone, P., Bellia, G., Franconi, F., Simoni, L., Attar, M., Zagni, E., Haggiag, S., et al. (2015) · The Scientific World JOURNAL · doi:10.1155/2015/787451 · Cited by 83 · see citing works

Interaction of polymorphisms in the genes encoding interleukin‐6 and estrogen receptor beta on the susceptibility to Parkinson's disease

Håkansson, A. S., Westberg, L., Nilsson, S., Buervenich, S., Belin, A. C., Holmberg, B., Sydow, O., Olson, L., Johnels, B., Eriksson, E., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30136 · Cited by 83 · see citing works

Dementia in Parkinson's disease: Is male gender a risk factor?

Cereda, E., Cilia, R., Klersy, C., Siri, C., Pozzi, B., Reali, E., Colombo, A., Zecchinelli, A., Mariani, C. B., Tesei, S., et al. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.02.024 · Cited by 83 · see citing works

Oestrogen Receptors and Signalling Pathways: Implications for Neuroprotective Effects of Sex Steroids in Parkinson’s Disease

Al-Sweidi, S., Sánchez, M. G., Bourque, M., Morissette, M., Dluzen, D. E., & Paolo, T. D. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02193.x · Cited by 82 · see citing works

Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens

Gillies, G. E., & McArthur, S. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.06.002 · Cited by 82 · see citing works

The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease

Baraka, A., Korish, A. A., Soliman, G. A., & Kamal, H. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.03.010 · Cited by 73 · see citing works

Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson’s disease

di Michele, F., Longone, P., Romeo, E., Lucchetti, S., Brusa, L., Pierantozzi, M., Bassi, A., Bernardi, G., & Stanzione, P. (2003) · Neurological Sciences · doi:10.1007/s10072-003-0115-1 · Cited by 72 · see citing works

Epidemiology of Parkinson disease in the city of Kolkata, India

Das, S., Misra, A. K., Ray, B. K., Hazra, A., Ghosal, M. K., Chaudhuri, A., Roy, T., Banerjee, T. K., & Raut, D. K. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f735a7 · Cited by 71 · see citing works

Cognitive and Motor Function in Patients with Parkinson's Disease with and without Depression

Cubo, E., Bernard, B., Leurgans, S. E., & Raman, R. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200011000-00006 · Cited by 70 · see citing works

Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson’s disease

Bourque, M., Dluzen, D. E., & Paolo, T. D. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.02.003 · Cited by 69 · see citing works

Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease

Rodriguez-Perez, A. I., Dominguez‐Meijide, A., Lanciego, J. L., Guerra, M. J., & Labandeira-García, J. L. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.06.004 · Cited by 69 · see citing works

Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients

Picillo, M., Erro, R., Amboni, M., Longo, K., Vitale, C., Moccia, M., Pierro, A., Scannapieco, S., Santangelo, G., Spina, E., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.04.023 · Cited by 69 · see citing works

Gender and non motor fluctuations in Parkinson's disease: A prospective study

Picillo, M., Palladino, R., Moccia, M., Erro, R., Amboni, M., Vitale, C., Barone, P., & Pellecchia, M. T. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.04.001 · Cited by 66 · see citing works

Gender distribution of patients with Parkinson’s disease treated with subthalamic deep brain stimulation; a review of the 2000–2009 literature

Hariz, G., Nakajima, T., Limousin, P. D., Foltynie, T., Zrinzo, L. U., Jahanshahi, M., & Hamberg, K. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.12.002 · Cited by 65 · see citing works

Gender differences in Parkinson’s disease: focus on plasma alpha-synuclein

Caranci, G., Piscopo, P., Rivabene, R., Traficante, A., Riozzi, B., Castellano, A. E., Ruggieri, S. A., Vanacore, N., & Confaloni, A. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-0972-6 · Cited by 62 · see citing works

Evidence for gender differences in cognition, emotion and quality of life in Parkinson's disease?

Heller, J., Dogan, I., Schulz, J. B., & Reetz, K. (2014) · Europe PMC (PubMed Central) · doi:10.14366/ad.2014.050063 · Cited by 62 · see citing works

Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy

Stacy, M. A., Murck, H., & Kroenke, K. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.09.023 · Cited by 60 · see citing works

Long‐term stability of effects of subthalamic stimulation in Parkinson's disease: Indian Experience

Kishore, A., Rao, R., Krishnan, S., Panikar, D., Sarma, G., Sivasanakaran, M. P., & Sarma, P. S. (2010) · Movement Disorders · doi:10.1002/mds.23269 · Cited by 59 · see citing works

Gender distribution in surgery for Parkinson's disease

Hariz, G., & Hariz, M. I. (2000) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00009-2 · Cited by 59 · see citing works

Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Joniec‐Maciejak, I., Ciesielska, A., Kurkowska‐Jastrzębska, I., Przybyłkowski, A. M., Członkowska, A., & Członkowski, A. (2009) · Brain Research · doi:10.1016/j.brainres.2008.12.081 · Cited by 58 · see citing works

A mitochondrial location for haemoglobins—Dynamic distribution in ageing and Parkinson's disease

Shephard, F., Greville‐Heygate, O., Marsh, O., Anderson, S. H., & Chakrabarti, L. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.12.001 · Cited by 58 · see citing works

Dopamine transporter function differences between male and female CD-1 mice

Bhatt, S. D., & Dluzen, D. E. (2005) · Brain Research · doi:10.1016/j.brainres.2004.12.013 · Cited by 58 · see citing works

LRRK2 mutations in Parkinson's disease: Confirmation of a gender effect in the Italian population

Cilia, R., Siri, C., Rusconi, D., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.04.016 · Cited by 57 · see citing works

Gender-specific role of mitochondria in the vulnerability of 6-hydroxydopamine-treated mesencephalic neurons

Misiak, M., Beyer, C., & Arnold, S. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.04.009 · Cited by 55 · see citing works

Gender differences on motor and non-motor symptoms of de novo patients with early Parkinson’s disease

Chinese Parkinson Study Group, Yang, S. T., Gu, Z., An, J., & Chan, P. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1879-1 · Cited by 55 · see citing works

Frequency and treatment of depressive symptoms in a Parkinson's disease registry

Althaus, A., Becker, O. A., Spottke, A. E., Dengler, R., Schneider, F. W., Kloß, M., Eggert, K. M., Oertel, W. H., Dillmann, U., Herting, B., et al. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.01.016 · Cited by 52 · see citing works

Gender differences in quality of life following subthalamic stimulation for Parkinson's disease

Hariz, G., Limousin, P. D., Zrinzo, L. U., Tripoliti, E., Avilés-Olmos, I., Jahanshahi, M., Hamberg, K., & Foltynie, T. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12127 · Cited by 52 · see citing works

Clinical features associated with REM sleep behavior disorder symptoms in the early stages of Parkinson’s disease

Bugalho, P., da Silva, J. A., & Neto, B. M. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5679-0 · Cited by 52 · see citing works

Gender differences and estrogen effects in parkin null mice

Rodríguez‐Navarro, J. A., Solano, R. M., Casarejos, M. J., Gómez, A., Perucho, J., de Yébenes, J. G., & Mena, M. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05569.x · Cited by 51 · see citing works

Kin‐cohort analysis of LRRK2‐G2019S penetrance in Parkinson's disease

Goldwurm, S., Tùnesi, S., Tesei, S., et al. (2011) · Movement Disorders · doi:10.1002/mds.23807 · Cited by 50 · see citing works

Gender influence on selection and outcome of deep brain stimulation for Parkinson′s disease

Kishore, A., Chandran, S., Krishnan, S., Rao, R., Sarma, P. S., & Sarma, P. (2014) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.128557 · Cited by 47 · see citing works

Gender differences in nigrostriatal dopaminergic innervation are present at young-to-middle but not at older age in normal adults

Wong, K. K., Müller, M. L. T. M., Kuwabara, H., et al. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.05.013 · Cited by 45 · see citing works

Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease

Litim, N., Morissette, M., & Paolo, T. D. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.09.024 · Cited by 45 · see citing works

Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP+ in female, but not male rats

Disshon, K. A., & Dluzen, D. E. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02329-5 · Cited by 44 · see citing works

Sex Differences in the Clinical Progression of Parkinson's Disease

Dahodwala, N. A., Pei, Q., & Schmidt, P. N. (2016) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1016/j.jogn.2016.05.002 · Cited by 44 · see citing works

Evidence for Gender Differences in Cognition, Emotion and Quality of Life in Parkinson’s Disease?

Helle, J. (2014) · Aging and Disease · doi:10.14336/ad.2014.050063 · Cited by 43 · see citing works

Gender Difference in the Interaction of Smoking and Monoamine Oxidase B Intron 13 Genotype in Parkinson’s Disease

Kelada, S. N., Costa‐Mallen, P., Costa, L. G., et al. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00061-x · Cited by 39 · see citing works

Progesterone prevents depression-like behavior in a model of Parkinson's disease induced by 6-hydroxydopamine in male rats

Casas, S., Menéndez, S. G., Cabrera, R., et al. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.012 · Cited by 37 · see citing works

Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice

Lewis, C., & Dluzen, D. E. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.011 · Cited by 36 · see citing works

AC-186, a Selective Nonsteroidal Estrogen Receptor β Agonist, Shows Gender Specific Neuroprotection in a Parkinson’s Disease Rat Model

McFarland, K., Price, D. L., Davis, C. N., Ma, J., Bonhaus, D. W., Burstein, E. S., & Olsson, R. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400132u · Cited by 36 · see citing works

Fractal analysis of striatal dopamine re-uptake sites

Kuikka, J. T., Tiihonen, J., Karhu, J., Bergstr�m, K. A., & R�s�nen, P. (1997) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf01254238 · Cited by 36 · see citing works

Gender-specific brain regional variation of neurons, endogenous estrogen, neuroinflammation and glial cells during rotenone-induced mouse model of Parkinson’s disease

Mitra, S., Chakrabarti, N., Dutta, S., Ray, S., Bhattacharya, P., Sinha, P., & Bhattacharyya, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.052 · Cited by 36 · see citing works

Are Sleep Disturbances Preclinical Markers of Parkinson’s Disease?

dos Santos, A. B., Kohlmeier, K. A., & Barreto, G. E. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1488-7 · Cited by 34 · see citing works

Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice

Ookubo, M., Yokoyama, H., Kato, H., & Araki, T. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.011 · Cited by 33 · see citing works

Neuronal hemoglobin in mitochondria is reduced by forming a complex with α-synuclein in aging monkey brains

Yang, W., Li, X., Li, X., Li, X., & Yu, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7046 · Cited by 31 · see citing works

Sex differences in cognition among Chinese people with Parkinson’s disease

Gao, L., Nie, K., Tang, H., et al. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2014.08.032 · Cited by 29 · see citing works

Sex differences in cerebral energy metabolism in Parkinson's disease: A phosphorus magnetic resonance spectroscopic imaging study

Weiduschat, N., Mao, X., Beal, M. F., Nirenberg, M. J., Shungu, D. C., & Henchcliffe, C. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.02.003 · Cited by 27 · see citing works

Analysis of Mitochondrial haemoglobin in Parkinson's disease brain

Shephard, F., Greville‐Heygate, O., Liddell, S., Emes, R. D., & Chakrabarti, L. (2016) · Mitochondrion · doi:10.1016/j.mito.2016.05.001 · Cited by 27 · see citing works

The impact of biological sex and sex hormones on cognition in a rat model of early, pre-motor Parkinson’s disease

Betancourt, E., Wachtel, J., Michaelos, M., Haggerty, M., Conforti, J. M., & Kritzer, M. F. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.041 · Cited by 27 · see citing works

Transient gender-related effects in Parkinson’s disease patients with subthalamic stimulation

Romito, L. M., Contarino, M. F., & Albanese, A. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5381-2 · Cited by 26 · see citing works

Developmental Sex Differences in the Metabolism of Cardiolipin in Mouse Cerebral Cortex Mitochondria

Acaz‐Fonseca, E., Ortiz‐Rodriguez, A., López-Rodríguez, A. B., García‐Segura, L. M., & Astiz, M. (2017) · Scientific Reports · doi:10.1038/srep43878 · Cited by 26 · see citing works

Gender differences in the IL6 −174G>C and ESR2 1730G>A polymorphisms and the risk of Parkinson's disease

Luciano, M. S., Ozelius, L. J., Lipton, R. B., Raymond, D., Bressman, S., & Saunders-Pullman, R. J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.11.032 · Cited by 21 · see citing works

Gender differences in modulatory effects of tamoxifen upon the nigrostriatal dopaminergic system

Dluzen, D. E., & Mickley, K. R. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.10.007 · Cited by 20 · see citing works

Treatment of sleeping disorders should be considered in clinical management of Parkinson's disease

dos Santos, A. B., Barreto, G. E., & Kohlmeier, K. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00273 · Cited by 18 · see citing works

Prevalence of Parkinson’s Disease in Bulgaria

Milanov, I. G., Kmetska, K., Karakolev, B., & Nedialkov, E. (2001) · Neuroepidemiology · doi:10.1159/000054790 · Cited by 15 · see citing works

Genetic alteration in the dopamine transporter differentially affects male and female nigrostriatal transporter systems

Ji, J., Bourque, M., Paolo, T. D., & Dluzen, D. E. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.004 · Cited by 14 · see citing works

Exercise and cognitive functions in Parkinson's disease: Gender differences and disease severity

Teixeira-Arroyo, C., Rinaldi, N. M., Batistela, R. A., Barbieri, F. A., Vitório, R., & Gobbi, L. T. B. (2014) · Motriz Revista de Educação Física · doi:10.1590/s1980-65742014000400014 · Cited by 12 · see citing works

Cognitive function in Parkinson's disease: The influence of gender

Pasotti, C., Zangaglia, R., Sinforiani, E., Minafra, B., Bertaina, I., & Pacchetti, C. (2012) · Basal Ganglia · doi:10.1016/j.baga.2012.10.004 · Cited by 10 · see citing works

Fractal analysis of striatal dopamine re-uptake sites

Kuikka, J. T., Tiihonen, J., Karhu, J. J. T., et al. (1997) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050125 · Cited by 7 · see citing works

Sex and gender: modifiers of health, disease, and medicine

Mauvais-Jarvis, F., Bairey Merz, N., Barnes, P. J., Brinton, R. D., Carrero, J.-J., DeMeo, D. L., De Vries, G. J., Epperson, C. N., Govindan, R., Klein, S. L., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31561-0 · Cited by 2,001 · see citing works

Sex differences in obesity, lipid metabolism, and inflammation—A role for the sex chromosomes?

Zore, T., Palafox, M., & Reue, K. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.04.003 · Cited by 239 · see citing works

Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human

Jee, H. J., Lee, S. G., Bormate, K. J., & Jung, Y.-S. (2020) · Nutrients · doi:10.3390/nu12103080 · Cited by 111 · see citing works

Estrogenic plants: to prevent neurodegeneration and memory loss and other symptoms in women after menopause

Echeverria, V., Echeverria, F., Barreto, G. E., Echeverría, J., & Mendoza, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.644103 · Cited by 52 · see citing works

Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites

Jiang, Z., Wang, X., Zhang, H., Yin, J., Zhao, P., Yin, Q., & Wang, Z. (2023) · MedComm · doi:10.1002/mco2.268 · Cited by 50 · see citing works

Sex and gender considerations in dementia: a call for global research

Vila-Castelar, C., Udeh-Momoh, C., Aggarwal, N. T., & Mielke, M. M. (2023) · Nature Aging · doi:10.1038/s43587-023-00374-5 · Cited by 21 · see citing works

Usefulness of Parkinson's KinetiGraph in a Parkinson's disease clinic – Survey of 82 patients

Klingelhoefer, L., Rizos, A., Sauerbier, A., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.10.051 · Cited by 4 · see citing works

薬剤性Parkinson症候群 (7月第1土曜特集 Parkinson病) -- (Parkinson症候群)

葛原, 茂. (1998) · 医学のあゆみ

Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokers

Rose, K. N., Zorlu, M. M., Fassini, A., Lee, H., Cai, W., Xue, X., Lin, S., Kivisäkk, P., Schwarzschild, M. A., Chen, X., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00763-6 · Cited by 28 · see citing works

Analysis on the Effect of Heavy Metals and Genetics on the Prevalence of Parkinson’s Disease

Zhang, C. (2020) · International Conference on Public Health and Data Science (ICPHDS) · doi:10.1109/icphds51617.2020.00012 · Cited by 1 · see citing works

Parkinson’s Disease-Overview

Khaliq, F. (2021) · Journal of Regenerative Biology and Medicine · doi:10.37191/mapsci-2582-385x-3(6)-092 · Cited by 11 · see citing works